Connecting Drug Delivery
Issue No #108 Jun 2020
June 30th, 2020
Inside the magazine
COVID-19: A CATALYST FOR IMPLEMENTING CONNECTED HEALTHCARE PRODUCTS?
Napoleon Monroe analyses how COVID-19 is catalysing a wide range of reactions in healthcare, explaining how drug and device connectivity are essential to improving patient access to treatment – and patient outcomes – as well as reducing overall cost.
THE AWARD-WINNING CREDENCE CONNECT™ AUTO-SENSING INJECTION SYSTEM
John Merhige explains how connectivity that is universally applicable to any existing prefilled syringe platform adds value throughout the ecosystem, both including and beyond the “compliance business model”.
POLYMERIC EMI SHIELDING: PROVIDING A MORE SECURE FUTURE FOR PATIENTS
Marnik Vaes, Leen-Pieter Deurloo and Martin Sas discuss the role of polymeric electromagnetic interference shielding in providing a more secure future for patients in a connected world.
SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?
Gaël Senée and Arnaud Guillet explore the benefits of Mallya – a smart sensor that turns conventional injection pens into connected devices. They also discuss the crucial role Biocorp’s connected prefilled syringe, Injay, could play in future COVID-19 vaccination programmes.
RISKS AND REAL-WORLD SOLUTIONS FOR CONNECTED MEDICAL DEVICES
Tom Oakley discusses the risks surrounding the use of connected drug delivery devices – and the real-world solutions that have either been proved or are being trialled.
APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION
Erin Miller looks at how connectivity can be used to enhance training to help address the challenges of accuracy and non-adherence when patients self-inject their medications.
DIGITAL HEALTH REFORMULATION: FROM HOPE TO HYPE TO HEALTH
Chelsea Williams, Ramin Rafiei and Ralph Howald discuss the accelerating value of digital health to improve the patient experience, achieve improved health outcomes, and increase health system efficiency and value.
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.
Beo Arana de Martinez
E3D – Elcam Drug Delivery Devices
MEETING THE CHALLENGES OF COVID-19
Beo Arana de Martinez and Ilan Shopen discuss the effects of the COVID-19 pandemic on patient populations, how the healthcare industry has intensified activity to fight the virus, and how connected devices that facilitate self-injection and remote monitoring are coming into their own.
UNLOCKING INSIGHT FOR PATIENT SUPPORT PROGRAMMES
Neil Williams and Andrew Tubb discuss how insights delivered by a cloud-based connected health system help patient support programmes to monitor and improve medication adherence.
Dr Andrei Yosef
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
With home care on the increase as a result of the coronavirus pandemic, Andrei Yosef looks at the crucial role played by connected home care medical devices and the data they generate.
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
Amber Witteman, Thijs Roebers and Dirk-Jan Opstelten introduce the company’s patented innovation, a wearable autoinjector customised to fit the wrist.
Adding value to Drug Delivery with Connectivity
In this video presentation, Kevin Deane looks at how connectivity applied in drug delivery technologies can provide better solutions for patients and for industry and add value for all stakeholders.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy